---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-21-013474"
form_type: "8-K"
ticker: "VSTM"
cik: "0001526119"
company_name: "Verastem, Inc."
filed_at: "2021-10-26T23:59:59+00:00"
generated_at: "2026-06-28T17:58:55.701586+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Verastem appoints Michelle Robertson to Board, replacing Gina Consylman effective Nov 15, 2021

## Summary
- Michelle Robertson appointed as Class III director and audit committee chair, effective Nov 15, 2021.
- Gina Consylman resigned from Board and audit committee, effective same date, to focus on other duties.
- Robertson is CFO of Editas Medicine; previously CFO of Momenta Pharmaceuticals through J&J acquisition.
- Robertson receives stock option grant of 63,493 shares upon joining, plus standard director compensation.

## SEC filing metadata
- accession: 0001558370-21-013474
- form_type: 8-K
- ticker: VSTM
- cik: 0001526119
- company_name: Verastem, Inc.
- filed_at: 2021-10-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1526119/000155837021013474/0001558370-21-013474-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1526119/000155837021013474/vstm-20211021x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-21-013474
- JSON: https://secwatch.observer/filing/0001558370-21-013474.json
- Plain text: https://secwatch.observer/filing/0001558370-21-013474.txt

## Key facts
- Executive change
  Michelle Robertson was elected as Class III Director and Audit Committee Chair at Verastem, Inc..
  - Action: elected
  - Role: Class III Director and Audit Committee Chair
  source text: On October 22, 2021, the Board unanimously voted to elect Ms. Michelle Robertson as a Class III director of the Company and to serve on the audit committee of the Board as chairperson, effective November 15, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1526119/000155837021013474/0001558370-21-013474-index.htm
- Executive change
  Gina Consylman resigned as Director at Verastem, Inc..
  - Action: resigned
  - Role: Director
  source text: On October 21, 2021, Gina Consylman resigned from the Board and its audit committee, effective November 15, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1526119/000155837021013474/0001558370-21-013474-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.